ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Cognitive dysfunction"

  • Abstract Number: 2916 • 2014 ACR/ARHP Annual Meeting

    Effects of Exercise on Body Composition, Cardiovascular Fitness, Muscle Strength, and Cognition in Patients with Rheumatoid Arthritis: A Randomised Controlled Trial of a Patient-Specific Exercise Programme

    Maha Azeez1, Ciara Clancy2, Tom O'Dwyer3, Fiona Wilson3 and Gaye Cunnane4, 1Rheumatology, St James's Hospital and Trinity College Dublin, Dublin, Ireland, 2Department of Physiotherapy, Trinity College Dublin, Dublin, Ireland, 3Physiotherapy, Trinity College Dublin, Dublin, Ireland, 4Dept of Rheumatology, St James's Hospital and Trinity College Dublin, Dublin, Ireland

    Background/Purpose Rheumatoid Arthritis (RA) patients have lower levels of physical activity compared to their non-RA counterparts. Large proportions of patients with RA are overweight or…
  • Abstract Number: 2654 • 2014 ACR/ARHP Annual Meeting

    Cognitive Function in Systemic Lupus Erythematosus Patients with Past History of Neuropsychiatric Manifestations : A Longitudinal Study

    Yang Gao1, Yi Lo1, Jacky Wan2, Esther YY Lau2 and Mo Yin Mok1, 1Department of Medicine, University of Hong Kong, Hong Kong, Hong Kong, 2Department of Psychology, University of Hong Kong, Hong Kong, Hong Kong

    Background/Purpose: Cognitive impairment is commonly reported in patients with systemic lupus erythematosus (SLE) and its associations with neuropsychiatric involvement (NPSLE) and psychiatric factors have been…
  • Abstract Number: 2202 • 2013 ACR/ARHP Annual Meeting

    TNF-α Is Associated With Cognitive Impairment In Childhood-Onset Systemic Lupus Erythematosus

    Mariana Postal1, Nailu A. Sinicato1, Aline T. Lapa1, Karina Peliçari1, Bruna Bellini1, Paula T Fernandes2, Roberto Marini3 and Simone Appenzeller4, 1Medicine, State University of Campinas, Campinas, Brazil, 2Faculty of Physical Education, State University of Campinas, Campinas, Brazil, 3State University of Campinas, Campinas, Brazil, 4Medicine, Faculty of Medical Science, State University of Campinas Unicamp, São Paulo, Brazil

    Background/Purpose: Cognitive impairment is common in over 50% of SLE patients with active neurological and psychiatric disorders. Cytokine dysregulation and inflammation are mechanisms that may…
  • Abstract Number: 1602 • 2013 ACR/ARHP Annual Meeting

    Autoantibodies, Cytokines and Chemokines In Serum and Cerebrospinal Fluid Of SLE Patients With Cognitive Dysfunction

    Hilda Fragoso-Loyo1, Alí Duarte-García2, Sandra Juárez-Arellano3, Alba Cicero-Casarrubias4, Juanita Romero-Díaz5, Luis LLorente-Peters1 and Jorge Sánchez-Guerrero6, 1Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico, Mexico, 2Department of Medicine, Tufts Medical Center, Boston, MA, 3Department of Neurology, Instituto Nacional de Ciencias Medicas y Nutricion S.Z., Mexico city, Mexico, 4Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 5Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Mexico, 6Rheumatology, Mount Sinai Hospital and University Health Network, Toronto Canada, Toronto, ON, Canada

    Background/Purpose: The nature and pathogenesis and cognitive dysfunction (CD) in patients with SLE is unkown.To determine the presence and levels of autoantibodies, cytokines and chemokines…
  • Abstract Number: 1260 • 2013 ACR/ARHP Annual Meeting

    Serum S100β Is Associated With Neuropsychiatric Manifestations In Childhood-Onset Systemic Lupus Erythematosus

    Aline T. Lapa1, Mariana Postal1, Nailu A. Sinicato1, Bruna Bellini1, Paula T Fernandes2, Roberto Marini3 and Simone Appenzeller4, 1Medicine, State University of Campinas, Campinas, Brazil, 2Faculty of Physical Education, State University of Campinas, Campinas, Brazil, 3State University of Campinas, Campinas, Brazil, 4Medicine, Faculty of Medical Science, State University of Campinas Unicamp, São Paulo, Brazil

    Background/Purpose: Involvement of the central nervous system (CNS) in systemic lupus erythematosus (SLE) is an important source of morbidity and mortality.  S100β has been considered…
  • Abstract Number: 1108 • 2013 ACR/ARHP Annual Meeting

    Methylphenidate Improves Concentration, Energy and Mood In Fibromyalgia

    Robert S. Katz1, Hannah Bond2 and Frank Leavitt3, 1Rush Medical College, Chicago, IL, 2Rheumatology Associates, Chicago, IL, 3Rush University Medical Center, Chicago, IL

    Background/Purpose: Central nervous system stimulants such as methylphenidate appear to have short term benefits for naming speed and cognitive functioning in fibromyalgia (FMS).  Methylphenidate quickly…
  • Abstract Number: 2644 • 2012 ACR/ARHP Annual Meeting

    Functional Magnetic Resonance Imaging of Working Memory in Fibromyalgia: Support for a “Competing Demands” Theory of Cognitive Function in Chronic Pain

    Anson E. Kairys1, Gabriela Ramirez1, Eric Ichesco2, Johnson P. Hampson2, Richard E. Harris2, Daniel J. Clauw3, Tobias Schmidt-Wilcke2 and Jennifer M. Glass4, 1Department of Anesthesiology, Chronic Pain and Fatigue Research Center, University of Michigan, Ann Arbor, MI, 2Anesthesiology, University of Michigan, Ann Arbor, MI, 3Anesthesiology/Internal Medicine (Rheum), University of Michigan, Ann Arbor, MI, 4Psychiatry, University of Michigan, Ann Arbor, MI

    Background/Purpose: The primary symptom of fibromyalgia (FM) is chronic widespread pain; however, patients report additional symptoms including decreased concentration and memory. Deficits are seen mainly…
  • Abstract Number: 1878 • 2012 ACR/ARHP Annual Meeting

    Cognitive Manifestations of Fibromyalgia and Lupus

    Robert S. Katz and Frank Leavitt, Rush University Medical Center, Chicago, IL

    Background/Purpose: Similar cognitive complaints for patients with fibromyalgia and systemic lupus erythematosus (SLE) have been reported; however, inherently different deficits can share superficial similarities. The…
  • Abstract Number: 1451 • 2012 ACR/ARHP Annual Meeting

    Estrogen Receptor Alpha Deficiency Protects Against Cognitive Defects in Murine Lupus

    Melissa A. Cunningham1, Osama S. Naga2, Heather A. Boger3, Ann-Charlotte E. Granholm-Bentley3 and Gary S. Gilkeson4, 1Med/Rheumatology, MUSC, Charleston, SC, 2Medicine/Rheumatology, Medical University of South Carolina, Charleston, SC, 3Neuroscience, Medical University of SC, Charleston, SC, 4Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, SC

    Background/Purpose: Up to 80% of SLE patients have cognitive defects or affective disorders. The mechanism of CNS injury responsible for cognitive impairment is unknown.  Anti-dsDNA…
  • Abstract Number: 611 • 2012 ACR/ARHP Annual Meeting

    Impaired Diffusion Tensor Imaging Findings in the Corpus Callosum and Cingulum May Underlie Impaired Learning and Memory Abilities in Systemic Lupus Erythematosus

    Daphna Paran1, Elissa Ash2, Ira Litinsky1, Valerie Aloush1, Marina Anouk1, Dan Caspi3, Talma Hendler4 and Irit Shapira-Lichter4, 1Rheumatology, Tel Aviv Sourasky Medical Ctr, Tel-Aviv University, Tel Aviv, Israel, 2Neurology, Tel Aviv Sourasky Medical Ctr, Tel-Aviv University, Tel Aviv, Israel, 3Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 4Functional Brain Center, Wohl Institute for Advanced Imaging, Tel-Aviv Sourasky Medical Ctr, Tel-Aviv University, Tel Aviv, Israel

    Background/Purpose: Memory impairment is prevalent in systemic lupus erythematosus (SLE), however the pathogenesis is unknown. In a previous functional Magnetic Resonance Imaging (MRI) study we…
  • Abstract Number: 304 • 2012 ACR/ARHP Annual Meeting

    Burden of Childhood Central Nervous System Vasculitis: Identifying High Risk Factors for Poor Cognitive Outcome

    Peter J. Gowdie1, Marinka Twilt1, Pascal N. Tyrrell1, Robyn Westmacott2, Tania Cellucci1, Shehla Sheikh1, Nick Blancette1 and Susanne M. Benseler1, 1Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 2Psychology, The Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: Childhood primary angiitis of the CNS (cPACNS) is an increasingly recognized, reversible cause of severe neurological and psychiatric deficit such as stroke, refractory seizures…
  • Abstract Number: 281 • 2012 ACR/ARHP Annual Meeting

    The Pediatric Automated Neuropsychological Assessment Metrics – Reproducibility and Responsive to Change in Cognition in Childhood-Onset Lupus

    Patricia Vega-Fernandez1, Marisa S. Klein-Gitelman2, Jessica Hummel3, Erin C. Thomas4, Jennifer L. Huggins5, Frank Zelko6, Tresa Roebuck-Spencer7, Jun Ying8 and Hermine Brunner5, 1Division of Rheumatology, Cincinanti Children's Hospital Medical Center, Cincinnati, OH, 2Division of Rheumatology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 3Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Division of Rheumatology, Anne & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 5Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 6Pediatric Neuropsychology Service, Children's Memorial Hospital, Chicago, IL, 7Center for the Study of Human Operator Performance, University of Oklahoma, Norman, OK, 8Medicine-Internal Medicine-General Medicine, University of Cincinnati, Cincinnati, OH

    Background/Purpose: The Childhood-onset Systemic Lupus Erythematosus (cSLE) Neuropsychological Battery (AC&R 2010; 62: 1029-33) was introduced to standardize neuropsychological testing (NPT), specifically probing the domains Attention,…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology